Literature DB >> 2933196

Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity.

J H Playfair, J B De Souza, R R Freeman, A A Holder.   

Abstract

A purified 230,000 mol wt protein antigen from the lethal mouse malaria parasite Plasmodium yoelii YM which had previously been shown to be highly effective as a vaccine, was tested for its ability to stimulate specific helper T cells and T cells responsible for delayed hypersensitivity. Strong stimulation was found in both assays, but larger doses were required for delayed hypersensitivity, correlating well with the requirements for protection. It is suggested that T stimulation may be a requirement for effective protection by purified antigens in malaria.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2933196      PMCID: PMC1577400     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

Review 1.  The complexity of structures involved in T-cell activation.

Authors:  J W Goodman; E E Sercarz
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

2.  Antibody-independent mechanisms in the development of acquired immunity to malaria.

Authors:  W P Weidanz; J L Grun
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

3.  Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin.

Authors:  J Taverne; H M Dockrell; J H Playfair
Journal:  Parasite Immunol       Date:  1982-03       Impact factor: 2.280

4.  Immunization against blood-stage rodent malaria using purified parasite antigens.

Authors:  A A Holder; R R Freeman
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

5.  Cell-mediated immunity in mice vaccinated against malaria.

Authors:  B J Cottrell; J H Playfair; B J De Souza
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

6.  Killing of blood-stage murine malaria parasites by hydrogen peroxide.

Authors:  H M Dockrell; J H Playfair
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

8.  Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.

Authors:  R R Freeman; A J Trejdosiewicz; G A Cross
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

9.  Biological functions of t cell lines with specificity for the intracellular bacterium Listeria monocytogenes in vitro and in vivo.

Authors:  S H Kaufmann; H Hahn
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

10.  Endotoxin-induced serum factor kills malarial parasites in vitro.

Authors:  J Taverne; H M Dockrell; J H Playfair
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

View more
  6 in total

1.  Immunization of mice against blood-stage Plasmodium yoelii malaria with isoelectrically focused antigens and correlation of immunity with T-cell priming in vivo.

Authors:  J B De Souza; J H Playfair
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

2.  Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice.

Authors:  J H Playfair; J B De Souza
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

3.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

Authors:  J Taverne; J Tavernier; W Fiers; J H Playfair
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

4.  In vivo testing of subunit vaccines against malaria sporozoites using a rodent system.

Authors:  A A Lal; V F de la Cruz; M F Good; W R Weiss; M Lunde; W L Maloy; J A Welsh; T F McCutchan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

Authors:  S Kumar; A Yadava; D B Keister; J H Tian; M Ohl; K A Perdue-Greenfield; L H Miller; D C Kaslow
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

6.  Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model.

Authors:  Davison Sangweme; Clive Shiff; Nirbhay Kumar
Journal:  Exp Parasitol       Date:  2009-04-12       Impact factor: 2.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.